Science and Enterprise

Tag: equity

  • Device Maker Teleflex Acquires Biomedical Materials Company

    Teleflex Inc., a medical device provider in Limerick, Pennsylvania, has acquired Semprus BioSciences in Cambridge, Massachusetts, a developer of coatings for medical implants. The deal has an immediate value of $30 million. Teleflex is a manufacturer of medical devices for vascular access, including catheters and dialysis access products. The company also develops devices for regional…

  • Merck Serono, Compugen to Form Toxicity Biomarkers Start-Up

    Merck Serono, a division of the global pharmaceutical company Merck in Geneva, Switzerland and the drug discovery company Compugen in Tel Aviv, Israel have agreed to form Neviah Genomics, a new enterprise to develop biomarkers for the prediction of drug-induced toxicity. While some financial arrangements were revealed, the total value of the deal was not…

  • Nanotech Window Glass Developer Lands $55M in Venture Funds

    Soladigm, a developer of energy-efficient office building window glass in Milpitas, California, secured $55 million in series D venture funding, the fourth financing cycle after initial start-up. The funding round, led by Reinet Investments and NanoDimension, join current investors DBL Investors, GE, Khosla Ventures, Navitas Capital, Sigma Partners, and The Westly Group. Soladigm’s lead product,…

  • Venture Fund to Invest $442M in Europe, U.S. Start-Ups

    The venture capital company Index Ventures, based in London, unveiled a €350 million ($442 million) fund to invest largely in start-up technology companies. The company expects to focus its new investments on European enterprises, but include start-ups in the U.S. and Israel as well. Index Ventures plans to concentrate on seed and early-stage investments in…

  • Blood Disease Start-Up Lands $40.7M in Venture Funding

    Global Blood Therapeutics Inc., a biotechnology company in San Francisco launched today with $40.7 million in funding from venture capital company Third Rock Ventures. The company plans to develop small molecule drugs to treat genetic blood disorders, such as sickle cell disease. The company’s founders include three biomedical researchers from University of California in San…

  • Biomarker Diagnostics Company Gains $40M in Venture Funding

    Astute Medical Inc. in San Diego, a developer of biomarker-based medical diagnostics, says it completed $40.4 million in series C venture financing, the third cycle of funding after initial start-up. The funding round was led by MPM Capital and included new investor Kaiser Permanente Ventures, as well as existing investors De Novo Ventures, Delphi Ventures,…

  • IVF Assessment Company Lands $18M in Venture Capital

    Auxogyn Inc., in Menlo Park, California, a developer of viability tests of embryos during in vitro fertilization (IVF) procedures, has raised $18 million in series B venture funds, the second round of financing after initial start-up. The financing was led by new investor SR One — the corporate venture capital arm of GlaxoSmithKline — and…

  • Solar Developer Secures $70 Million in Venture Financing

    Nanosolar Inc. in San Jose, California says it has raised $70 million in new capital for further research and development and to expand production. This later-stage investment round includes current and new investors OnPoint Technologies, Inc., Mohr Davidow Ventures, Ohana Holdings LLC, and Family Offices. In February, the company secured $20 million in venture financing…

  • Medical Device Company Lands $30M for Clinical Trials

    Kona Medical Inc., a medical device developer in Bellevue, Washington, has secured $30 million in series C venture funds, the third financing cycle after initial start-up. The round was led by an undisclosed large-cap medical technology company, and joined by existing investors Essex Woodlands, Domain Associates, Morgenthaler Ventures, and BioStar Ventures. Kona Medical, founded in…

  • Venture Fund Raises $50M for Cleantech, Materials Start-Ups

    Pangaea Ventures Ltd. in Vancouver, British Columbia has raised $US 50 million for its Pangaea Ventures Fund III that aims to invest in early-stage cleantech companies using advanced materials technologies. Pangaea says the new investment fund expects to eventually raise $100 million. The limited partners in the fund are corporate and private-equity venture investors including…